Information  X 
Enter a valid email address

Ergomed plc (ERGO)

  Print      Mail a friend

Monday 16 April, 2018

Ergomed plc

Directors' Dealing

RNS Number : 0779L
Ergomed plc
16 April 2018
 

Ergomed Plc

("Ergomed" or the "Company")

 

Directors' Dealing

 

Ergomed, a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that on 16 April 2018, Dr Miroslav Reljanovic, founder and Executive Vice-Chairman of the Company, sold 4,000,000 ordinary shares of 1p each in the Company ("Share(s)") at a price of 190p per Share to meet institutional demand. 

 

Following this transaction, Dr Miroslav Reljanovic's holding has reduced to 11,132,237 shares (representing 24.9 per cent. of the Company's issued share capital).

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr Miroslav Reljanovic

2

Reason for the notification

a)

Position/status

Founder and Executive Vice-Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ergomed Plc

b)

Legal Entity Identifier

213800BVS8I9VMC1AP84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1 pence each

 

 

 GB00BN7ZCY67

b)

Nature of the transaction

Sale of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

190p

4,000,000



e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

Volume: 4,000,000

Price: 190p

Aggregated volume: £7,600,000

f)

Date of the transaction

16 April 2018

g)

Place of the transaction

London Stock Exchange, AIM

 

 

Enquiries:

 

Ergomed plc

Tel: +44 (0) 1483 503205

Stephen Stamp (Chief Executive Officer)




Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)


James Black (Joint Broker)


 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHIFMITMBABBJP

a d v e r t i s e m e n t